Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis

Abstract
COVID-19, the disease caused by SARS-CoV-2 (1), was declared a pandemic by the World Health Organization (WHO) in March 2020 (2). While awaiting a vaccine, several antivirals are being used to manage the disease with limited success (3, 4). To expand this arsenal, we screened 4 compound libraries: a United States Food and Drug Administration (FDA) approved drug library, an angiotensin converting enzyme-2 (ACE2) targeted compound library, a flavonoid compound library as well as a natural product library. Of the 121 compounds identified with activity against SARS-CoV-2, 7 were shortlisted for validation. We show for the first time that the active form of Vitamin D, calcitriol, exhibits significant potent activity against SARS-CoV-2. This finding paves the way for consideration of host-directed therapies for ring prophylaxis of contacts of SARS-CoV-2 patients.
Competing Interest Statement
The authors have declared no competing interest.
Subject Area
- Biochemistry (7562)
- Bioengineering (5503)
- Bioinformatics (20753)
- Biophysics (10308)
- Cancer Biology (7964)
- Cell Biology (11625)
- Clinical Trials (138)
- Developmental Biology (6598)
- Ecology (10177)
- Epidemiology (2065)
- Evolutionary Biology (13589)
- Genetics (9530)
- Genomics (12830)
- Immunology (7917)
- Microbiology (19525)
- Molecular Biology (7651)
- Neuroscience (42025)
- Paleontology (307)
- Pathology (1254)
- Pharmacology and Toxicology (2195)
- Physiology (3261)
- Plant Biology (7028)
- Synthetic Biology (1949)
- Systems Biology (5422)
- Zoology (1113)